Abstract
The authors report poor labeling of Tc-99m red blood cells (RBCs) in vivo in a radionuclide intestinal bleeding study of a patient who had recently undergone frequent blood transfusions. The existence of RBC antibodies, as a result of the recent blood transfusions in this patient, was one of the causes of the poor labeling. In radionuclide bleeding studies with patients with recent blood transfusion, Tc-99m HSA-D must be chosen instead of Tc-99m RBCs in vivo.
MeSH terms
-
Adult
-
Blood Transfusion*
-
Erythrocytes
-
Female
-
Gastrointestinal Hemorrhage / diagnostic imaging*
-
Humans
-
Leukemia, Myeloid, Acute / therapy
-
Radionuclide Imaging
-
Radiopharmaceuticals*
-
Sodium Pertechnetate Tc 99m
-
Technetium Tc 99m Aggregated Albumin
-
Technetium Tc 99m Pentetate
-
Tin Polyphosphates
Substances
-
Radiopharmaceuticals
-
Technetium Tc 99m Aggregated Albumin
-
Tin Polyphosphates
-
technetium Tc 99m DTPA HSA
-
Sodium Pertechnetate Tc 99m
-
Technetium Tc 99m Pentetate